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Characterisation of the conformational states adopted during protein folding, including globally unfold-
ed/disordered structures and partially folded intermediate species, is vital to gain fundamental insights
into how a protein folds. In this work we employ fast photochemical oxidation of proteins (FPOP) to
map the structural changes that occur in the folding of the four-helical bacterial immunity protein,
Im7. Oxidative footprinting coupled with mass spectrometry (MS) is used to probe changes in the solvent
accessibility of amino acid side-chains concurrent with the folding process, by quantifying the degree of
oxidation experienced by the wild-type protein relative to a kinetically trapped, three-helical folding
intermediate and an unfolded variant that lacks secondary structure. Analysis of the unfolded variant
by FPOP–MS shows oxidative modiﬁcations consistent with the species adopting a solution conformation
with a high degree of solvent accessibility. The folding intermediate, by contrast, experiences increased
levels of oxidation relative to the wild-type, native protein only in regions destabilised by the amino acid
substitutions introduced. The results demonstrate the utility of FPOP–MS to characterise protein variants
in different conformational states and to provide insights into protein folding mechanisms that are
complementary to measurements such as hydrogen/deuterium exchange labelling and U-value analysis.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Mass spectrometry (MS)-based techniques are being employed
increasingly to assist in the structural characterisation of biomole-
cules, such as proteins, protein assemblies and protein–ligand
complexes [1,2]. Numerous methods have been developed for this
purpose, including covalent labelling, hydrogen/deuterium
exchange (HDX), and chemical crosslinking, which can be mapped
at a residue-speciﬁc level using MS analysis [1–6].
Fast photochemical oxidation of proteins (FPOP) is an emerging
MS-based technique with the potential to elucidate conformational
changes in proteins resulting from folding/unfolding processes
[7–15] and for probing changes in solvent accessibility that
accompany ligand binding [16–18]. The FPOP approach requires
the addition of small quantities of H2O2 (typically 0.02% (v/v)) to
protein-containing solutions immediately prior to infusion
through a capillary system and irradiation with a pulsed laser
[19]. This procedure generates hydroxyl radicals that react with
potentially any solvent accessible amino acid side-chain (althoughreaction rates for each amino acid differ signiﬁcantly) [4], resulting
typically in +16 Da mass additions, although additional modiﬁca-
tions may also be observed [4,20]. Addition of quenching reagents
such as glutamine or histidine reduces the hydroxyl radical life-
time to approximately 1 ls [17,12,21]. The labelling time after
each laser pulse, therefore, is faster than most protein unfolding/
refolding reactions, allowing each protein conformation to be
labelled effectively instantaneously in an experiment. Hence, both
spatial (amino acid labelling sites) and temporal information
regarding protein folding can be obtained [7–15]. FPOP–MS serves
as a complementary technique to the more established method of
HDX-MS [22], but the covalent nature of the modiﬁcations in
FPOP–MS permits more rigorous sample handling procedures
downstream of the labelling process without loss of information.
Mutational analysis of protein folding and unfolding kinetics
(U-value analysis) is one of the most powerful approaches used
to dissect protein folding mechanisms [23]. The information from
these analyses can then be used to introduce mutations that sta-
bilise partially folded intermediates or more highly unfolded states
of a protein at equilibrium, allowing their direct structural analysis.
Here, we have chosen to study the four-helix, bacterial immunity
protein, Im7 (Fig. 1) [24] and two mutant constructs. The ﬁrst con-
struct, L53A I54A Im7 (DM Im7), has two amino acid changes in
helix III [25]. This species populates the on-pathway folding
Fig. 1. (a) The native structure of Im7, which has a four-helix fold (PDB accession
1AYI [41]). The locations of the amino acid substitutions with Ala are shown for (b)
DM Im7 and (c) TM Im7. (d) Schematic of the folding energy landscape of Im7
showing the species populated during folding (U, unfolded state; I, intermediate
state; N, native state; TS1 and TS2, the ﬁrst and second transition states). Structures
generated from molecular dynamics simulations are shown for TS1, I and TS2
[27,38]. Water molecules are shown (red spheres) that are displaced from the core
as the protein folds. The four helices present in native, wild-type (WT) Im7 are
coloured (I) red, (II) green, (III) purple, and (IV) yellow.
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retain native-like secondary structure in helices I and IV, with par-
tial formation of helix II and complete loss of helix III [25–27]. The
second variant, L18A L19A L37A Im7 (TM Im7), was employed
because these amino acid substitutions prevent Im7 folding and
stabilise the unfolded state at equilibrium. This unfolded variant
has been shown to be compact, retaining few ﬁxed tertiary interac-
tions and lacking persistent helical structure [28].
Here, we use MS-based techniques to interrogate the structures
of Im7, DM Im7 and TM Im7. Initial studies utilising native electro-
spray ionisation-ion mobility spectrometry–mass spectrometry
(ESI-IMS–MS) failed to distinguish between native Im7, the inter-
mediate DM Im7 and unfolded TM Im7. We show that when the
proteins were labelled using the FPOP technique, a correlation
between the extent of structural destabilisation and the degree
of covalent modiﬁcation was observed. This demonstrates that
FPOP can be implemented successfully to probe differences in
the conformational properties and dynamics of proteins.
Furthermore, localisation of oxidation sites shows that destabilisa-
tion of secondary structure in a particular region leads to an
increase in the levels of oxidative labelling in the speciﬁc region
of the sequence involved. This is consistent with FPOP permitting
discrimination of the conformational dynamics of speciﬁc amino
acid side-chains in regions of protein structure, producing datathat are complementary to information about the main chain pro-
vided by HDX.
2. Materials and methods
2.1. Materials
Im7 constructs containing an N-terminal hexahistidine tag
(ME(His)6) were overexpressed in Escherichia coli and puriﬁed as
described previously [24,29].
2.2. Circular dichroism
Far-UV circular dichroism (CD) spectra were recorded on a
Chirascan CD spectrophotometer (Applied Photophysics,
Leatherhead, Surrey, UK) using a 1 mm path length cuvette.
Solutions contained protein at a concentration of 0.1 mg/mL in
10 mM sodium phosphate buffer, pH 7.0. Spectra shown are the
average of three scans that were acquired over the range 190–
260 nm with a bandwidth of 1 nm and a scan speed of
20 nmmin1. The buffer contribution was subtracted from the
spectrum of each sample.
2.3. Native electrospray-ion mobility spectrometry–mass spectrometry
Lyophilised proteins (5 lM) were dissolved in 50 mM ammoni-
um acetate buffer, pH 6.9 and desalted using Micro BioSpin 6 (Bio-
Rad, Hemel Hempstead, UK) columns. ESI-IMS–MS experiments
were performed using a Synapt HDMS mass spectrometer
(Waters Ltd., Wilmslow, Manchester, UK). Sample introduction
was achieved by nano-ESI using in-house prepared gold-plated
borosilicate capillaries. Typically, a capillary voltage of 1.4 kV
was applied, the cone voltage was set to 40 V, and a backing pres-
sure of 4.5 mBar was used. IMS separation was achieved using a
wave height of 5 V, and a wave velocity of 250 ms1. Drift times
were calibrated using experimentally determined CCSs of native
proteins and applying a procedure described in detail elsewhere
[30–33]. CCSs were calculated from coordinates deposited in the
Protein Data Bank using a scaled projection approximation (PSA)
[34]. Aqueous CsI was used for m/z calibration. Data were pro-
cessed using MassLynx v4.1 and Driftscope v2.5 software (Waters
Ltd., Wilmslow, Manchester, UK).
2.4. Fast photochemical oxidation
Samples contained protein (10 lM) in 10 mM sodium phos-
phate buffer, pH 7.0 and were supplemented with 20 mM L-glu-
tamine. 0.02% v/v H2O2 (ﬁnal concentration) was added
immediately prior to laser irradiation from a 30% v/v stock solu-
tion. The sample was infused through a fused silica capillary (inner
diameter 100 lm), which had a window etched with a butane
torch, at a ﬂow rate of 20 lL/min. Hydroxyl radicals were generat-
ed by exposing the sample (through the etched window) to irra-
diation from a Compex 50 Pro KrF excimer laser operating at
248 nm (Coherent Inc., Ely, UK) with frequency of 15 Hz and a laser
beam width of <3 mm at the point of irradiation. These solution,
ﬂow and laser pulse conditions ensure each bolus of protein-
containing solution is exposed only once to laser irradiation and
that conformational averaging during labelling does not occur, as
the labelling reaction is on a faster time scale than any unfolding
event which may occur, due to the presence of the quenching
reagent L-glutamine [12,19,21]. The capillary outﬂow (100 lL)
was collected in a 1.5 mL tube that contained 20 lL of a 100 mM
L-methionine/1 lM catalase solution in 10 mM sodium phosphate
buffer, pH 7.0 to degrade residual H2O2 and quench any hydroxyl
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out being subjected to laser irradiation, to correct for any back-
ground oxidation that may occur on the timescale of the FPOP
experiment. 50 lL of protein-containing solutions were digested
with trypsin for 16 h at 37 C using a 1:50 (w/w) enzyme:protein
ratio. The samples were frozen on dry ice and stored at80 C until
analysis.2.5. Liquid chromatography–mass spectrometry
Following proteolysis, proteins were analysed intact using an
Ultimate 3000 nanoLC system (Dionex, ThermoFisher UK Ltd.,
Hemel Hempstead, UK). 1 lL of each sample was loaded onto a
MassPREP protein desalting column (Waters Ltd., Manchester),
that was washed with 2% (v/v) solvent B in solvent A (solvent A
was 0.1% (v/v) formic acid in water, solvent B was 0.1% (v/v) formic
acid in acetonitrile) for 5 min at 40 lL min1. After valve switching,
the bound proteins were eluted using a fast gradient of 2–40% sol-
vent B in A over 1 min at 0.5 lL min1. The column was subse-
quently washed with 95% solvent B in A for 6 min and re-
equilibrated with 5% B in A for the next injection. The column elu-
ant was directly infused into a Synapt G2S mass spectrometer
(Waters Ltd, Wilmslow, Manchester, UK) via a Z-spray nanoﬂow
electrospray source.
For mapping of peptides, data-dependent LC–MS/MS was con-
ducted on an Ultimate 3000 nanoLC system (Dionex,
ThermoFisher UK Ltd., Hemel Hempstead, UK) interfaced to a
Synapt HDMS mass spectrometer (Waters Ltd., Wilmslow,
Manchester, UK). Peptides (1 lL) were injected onto a PepMap
C18, 100 lm i.d.  15 cm column and then separated by gradient
elution of 2–45% solvent B (0.1% (v/v) formic acid in acetonitrile)
in solvent A (0.1% (v/v) formic acid in water) over 60 min at
0.35 lL min1.
The Synapt HDMS was operated in positive TOF mode using a
capillary voltage of 3.8 kV, cone voltage of 20 V, backing pressure
of 2.47 mbar (8.57 for the Synapt G2S) and a trap bias of 4 V. The
source temperature was 80 C. Argon was used as the buffer gas
at a pressure of 5.0  104 mBar (9.17  103 mBar for the
Synapt G2S) in the trap and transfer regions. Mass calibration
was performed by a separate injection of sodium iodide at a con-
centration of 2 lg/ll. For peptide LC–MS/MS, GluFib was infused
as a lock mass calibrant with a one second lock spray scan taken
every 30 s during acquisition. Ten scans were averaged to deter-
mine the lock mass correction factor. Data acquisition was
achieved using data dependent analysis with a one second MS scan
over an m/z range of 350–3000 being followed by three 1 s MS/MS
scans taken of the three most intense ions in the MS spectrum over
an m/z range of 50–2000. The collision energy applied was depen-
dent upon the charge state and mass of the ion selected. Dynamic
exclusion of 60 s was used. Data processing was performed using
the MassLynx v4.1 suite of software supplied with the mass spec-
trometer and PEAKS Studio 7 (Bioinformatics Solutions, Ontario,
Canada).
Peptide level quantitation of oxidation was achieved by calcu-
lating background-corrected % modiﬁed values using LC/MS signal
intensities of the modiﬁed peptides (Imodiﬁed) relative to their
unmodiﬁed counterparts (Iunmodiﬁed), using the following equation:Fig. 2. CD Spectroscopy of Im7 constructs. Native WT Im7 (green solid line) exhibits
a CD spectrum characteristic of an a-helical protein. DM Im7 (orange dashed line)
has reduced helical content, whilst TM Im7 (red dotted line) lacks the native helices.% modified ¼
P
Imodified
Iunmodified þ
P
Imodified
ð1Þ
Values were normalised to take into account background levels
of oxidation by performing the same analysis on samples not sub-
jected to laser irradiation. The data for DM Im7 and TM Im7
peptides (% modiﬁedmutant) were then normalised using the %modiﬁed values for the corresponding peptides in native Im7 (%
modiﬁedWT) to determine the change in oxidation observed, using
the following equation:
% change ¼ % modifiedmutant % modifiedWT ð2Þ3. Results and discussion
3.1. Global changes in secondary structure are induced by mutations
For this study, WT Im7 and two variants were selected for ana-
lysis using FPOP because of their known differences in structure
which have been described previously using a wealth of kinetic
and structural analyses [25,28]. DM Im7 populates an intermedi-
ate, partially folded state at equilibrium which contains three of
the four native a-helices, whilst TM Im7 populates an unfolded
ensemble which is compact but lacks persistent secondary struc-
ture [25,28].
The differences in the secondary structure content of each vari-
ant under the solution conditions used for oxidative labelling were
studied by circular dichroism (CD) spectroscopy (Fig. 2). The result-
ing spectra show that native WT Im7 has a spectrum with negative
maxima at 208 and 222 nm, characteristic of a protein with a high
degree of a-helicity. The intensities of these negative maxima
decreased in DM Im7, indicating a loss of secondary structure con-
sistent with the unfolding of helix III (Fig. 2). Finally, TM Im7 exhi-
bits a CD spectrum which is characteristic of a protein that is
substantially unfolded (Fig. 2). Deconvolution of the observed CD
spectra indicates that native WT Im7 has approximately 50% a-he-
lical content, whilst DM Im7 is approximately 45% helical and for
TM Im7 the helical content is decreased further to approximately
9%, consistent with previous results [25,28].
3.2. The Im7 variants have similar collision cross-sections measured
using ESI-IMS–MS
We next set out to determine whether native ESI-IMS–MS could
be used to detect differences in the structural properties of Im7,
DM Im7 and TM Im7. Despite these proteins having very different
secondary structure content, they all adopt relatively compact
globular structures in solution (with hydrodynamic radii values
for WT Im7, DM Im7 and TM Im7 measured as 19.3, 19.0 and
26.1 Å, respectively) [26,28]. The native ESI-IMS–MS spectra of the-
se proteins are qualitatively similar, displaying just two main
charge states (5+ and 6+) consistent with compact structures
(Fig. 3a–c). The rotationally averaged collision cross-sections
(CCSs) of the ions at the two lowest observed charge states did
Fig. 3. Native ESI-IMS–MS spectra of (a) Im7, (b) DM Im7, and (c) TM Im 7. (d and e) CCSs of the Im7 constructs, using the colour scheme in (a) to (c). Arrival Time
Distributions (ATDs) of (d) 5+ and (e) 6+ charge states are shown. The theoretical CCS from the Im7 structure (PDB accession 1AYI [41] is 1165 Å2). The measured CCSs of the
5+ ions are within 7% of the estimated value from the crystal structure, indicating good agreement with the theoretical CCS value (the error associated with the calibration of
CCSs is 67.5%) [30].
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(5+) and 1302 Å2 (6+)), indicating that these gas-phase conformers
are too similar in CCS to be resolved (Fig. 3d and e). Despite TM Im7
having a larger hydrodynamic radius in solution and presumably
adopting a larger number of conformations compared with its par-
tially folded and native counterparts, the CCS distributions of the
proteins are indistinguishable (Fig. 3d and e). This is likely because
the hydrophobic interactions which are stabilising the core of TM
Im7 in solution are perturbed in the gas-phase leading to collapse
[28,35,36]. Given that ESI-IMS–MS is particularly useful for deter-
mining the extent of disorder [37], i.e. conformational ﬂexibility, in
proteins, the data obtained here for Im7 likely reﬂect the global
lack of disorder in the unfolded and intermediate states that is pre-
sent in solution.
3.3. Global changes in oxidative labelling are observed in different
conformational variants of Im7
Im7, DM Im7 and TM Im7 were labelled using the FPOP proce-
dure outlined in the Materials and Methods section. Intact samples
of the labelled proteins were desalted online and analysed by MS.
Fig. 4a–c show the deconvoluted mass distributions of the oxidised
samples, with +16 Da mass additions observed to the correspond-
ing precursor upon laser irradiation in the presence of H2O2.
Oxidation of amino acid side-chains by hydroxyl radicals is not
only dependent on solvent accessibility, but also on amino acid
identity [4]. Consequently, it is important to consider the amino
acid substitutions present in the Im7 variants studied here and
any inﬂuence these may have on the rate of the oxidation reaction,
and hence the extent of modiﬁcation observed. In this instance, allof the amino acid substitutions introduce an alanine residue at the
expense of either a leucine or isoleucine. The rate constants for the
reactions of these amino acids with hydroxyl radicals show that
alanine reacts more slowly with hydroxyl radicals than either leu-
cine or isoleucine, with rate constants of 7.7  107, 1.7  109 and
1.8  109 M1 s1, respectively [4]. Thus, these substitutions
reduce the susceptibility of the protein to oxidation, ruling out
the possibility that any increased levels of oxidation simply result
from alteration in the amino acid composition of the variants.
Analysis of the mass distributions of the oxidised intact proteins
and quantiﬁcation of the ratio of unoxidised to oxidised protein
present in each sample was also performed. These data indicate
that introduction of amino acid substitutions in the Im7 sequence
results in the protein experiencing higher levels of oxidation
(Fig. 4d) (i.e. there is less unmodiﬁed protein present after FPOP).
Given that the variants remain compact, these differences most
likely result from alterations in the average secondary structure
content and average compactness (i.e. the width of the conforma-
tional ensemble) of each protein. In the case of DM Im7, both helix
III and the C-terminal seven amino acids of helix II are destabilised
[26], whilst for TM Im7, only 9% helical structure, on average, per-
sists [28]. The measured percentages of unmodiﬁed protein
remaining after FPOP are plotted in Fig. 4d, along with the estimat-
ed percentage of a-helical structure in each protein (from CD spec-
troscopy data). The results indicate that as the average a-helical
content of the protein decreases (as does the thermodynamic sta-
bility [25,27,28]), the protein becomes more susceptible to oxida-
tion. Thus, the data highlight the power of FPOP coupled with MS
analysis as a probe of the conformational properties of proteins.
The technique is highly sensitive to the presence of a hydrogen
Fig. 4. Deconvoluted mass distributions of (a) WT Im7, (b) DM Im7, and (c) TM Im7. Mass distribution of the H2O2 treated (but not laser irradiated) samples are shown in
black, and mass distributions of the laser irradiated samples are shown in colour. Peaks corresponding to the protein precursors are labelled 0, with other peaks labelled
according to the number of oxygen atoms incorporated as a result of oxidative labelling (1, 2, 3, etc). (d) Estimated % of unmodiﬁed protein remaining after FPOP (mean ± SEM
of three replicates analysed in triplicate is shown as bars) and estimated % helical content as determined by CD spectroscopy (shown as white squares) [25,28].
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chain oxidation by hydroxyl radicals in solution. This is analogous
to HDX-MS, where backbone amide hydrogens are exchanged for
deuterons, a process that is retarded when residues are involved
in hydrogen bonding networks or are buried from solvent [22].
3.4. Local changes in oxidative labelling are observed for different Im7
variants
The sites of oxidation were localised to the peptide level by use
of LC–MS analysis of tryptic Im7 peptides (Fig. 5a). Quantiﬁcation
of the extent of oxidation was performed for the three tryptic pep-
tides in which differences in oxidation levels between the three
proteins were detected. The data were normalised to determine
the change in oxidation experienced by each peptide from the pro-
tein variants relative to the corresponding peptide from WT Im7
(Fig. 5b). The results show that TM Im7 has an increase in oxidative
labelling across the entire sequence compared with native, WT Im7
(Fig. 5b), consistent with the global changes in oxidation experi-
enced by the protein (Fig. 4d). By contrast, DM Im7 exhibits spatial
differences in the changes in oxidation level observed, with only
two of the three peptides showing increases in oxidation levels
compared with the WT Im7 (Fig. 5b). One of these peptides
(44–70) corresponds to regions of the protein incorporating helix
III, which is known to be unfolded in DM Im7 [27,38]. The peptide
of DM Im7which does not show an increase in oxidation relative toWT Im7 (21–43) spans a portion of helix I and helix II, which are
native-like or partially formed, respectively, in the intermediate
state (Fig. 1d). Sequence coverage was poor beyond residue 70 of
Im7 (due to the presence of many trypsin-cleavable residues), so
this region of the protein was not analysed in sequence speciﬁc
detail.
The oxidation sites were next localised to speciﬁc amino acid
residues in the three tryptic peptides (Fig. 5a) by analysis of LC–
MS/MS data. LC–MS/MS spectra were assigned using automated
software and all assignments were veriﬁed manually. The rate con-
stants for the reaction of amino acid side-chains with hydroxyl
radicals are known, and span four orders of magnitude (from a rate
of 1.7  107 M1 s1 for Gly to 3.4  1010 M1 s1 for Cys [4,5]). The
most reactive residues, in order of reactivity when they are equally
accessible in bulk solution, have been shown to be: Cys, Met > Trp,
Phe, Tyr > Pro > His > Leu [39]. It can be seen that the side-chains
most susceptible to oxidation are those which are sulphur-contain-
ing, followed by those which are aromatic. Consequently, these
residues are considered the most reliable probes of solvent acces-
sibility and are considered further here [5].
The peptide comprising the N-terminal unstructured region and
helix I (residues 5–20) was found to be susceptible to oxidation at
two residues. In WT Im7, the oxidation site in this peptide was
identiﬁed solely as at position Y10 (Fig. 5a). A signiﬁcant increase
in the oxidation of this peptide in DM and TM Im7 indicates there
is increased ﬂexibility in the N-terminal region of the protein that
Fig. 5. (a) Sequence and secondary structure of WT Im7. Numbering shown is for native Im7, the construct used contains an additional 8 residues at the N-terminus
(MEHHHHHH-) for expression and puriﬁcation purposes [24,28,29]. The four helices are coloured (I) red, (II) green, (III) purple, and (IV) yellow. The sites of mutations in DM
Im7 are indicated with asterisks and the sites of mutations in TM Im7 with black circles. Residues where oxidation was identiﬁed in the three peptides investigated are shown
in bold. (b) Peptide level quantiﬁcation of oxidation levels in DM Im7 and TM Im7 (relative to the corresponding unoxidised peptide in the same sample). Data were
normalised to the extent of modiﬁcation observed in WT Im7 to track changes in the different proteins. Peptide 21–43 from DM Im7 shows no increase in modiﬁcation extent
relative to WT Im7.
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due F15, which is buried in the native state, was identiﬁed as an
oxidation product only in DM and TM Im7, indicating that this resi-
due becomes solvent accessible and available for modiﬁcation only
in the intermediate and unfolded variants. In a second peptide
comprising part of helix I and all of helix II (residues 21–43),
modiﬁcation sites were identiﬁed for residue A29 in the loop
between helix I and II, and in helix II itself (Fig. 5a). This helix is
partially formed in DM Im7 and its C-terminal portion has been
shown to be in dynamic exchange in the intermediate state using
NMR spectroscopy [26]. However, there were no residues in this
region where a signiﬁcant increase in oxidation level was observed
in the intermediate DM Im7 compared with WT native Im7
(Fig. 5b, centre), likely because the residues involved remain buried
[26]. Conversely, unfolding and exposure of this helix in TM Im7
leads to a signiﬁcant increase in the oxidation efﬁciency through-
out this region (Fig. 5b, centre). Interestingly residue F41, which
forms a part of the hydrophobic core of Im7, was not oxidised in
any of the samples, despite Phe being one of the most reactive side
chains and a reliable probe of solvent accessibility. This indicates
that in all the Im7 variants residue F41 remains buried. Solution
and molecular dynamics simulation data have shown this par-
ticular residue to be involved in many non-native contacts which
stabilise the intermediate state, possibly explaining why this resi-
due is not modiﬁed in DM Im7 despite its high reactivity [24,38].
Likewise, aromatic clusters persist in TM Im7, also likely involving
residue F41 [28]. The major oxidation sites identiﬁed in the peptide
comprising helix III and part of helix IV (residues 44–70) were Y55
and Y56, which are both located in helix III, with residue Y55 beingpartially buried in the native-state while Y56 is more solvent
exposed [40] (Fig. 5a). Thus, the susceptibility of these residues
to oxidation is signiﬁcantly enhanced upon unfolding of this helix
in both DM and TM Im7 (Fig. 5b, right). Together, the results
demonstrate that FPOP coupled to MS can provide insight into
the structure, ﬂexibility and dynamics of amino acid side-chains
in different protein conformers, and does not suffer from the
effects of conformational exchange that often rule out direct ana-
lyses of partially folded proteins using NMR spectroscopy.4. Conclusions
We have demonstrated the ability of FPOP–MS to differentiate
between three different sequence variants of Im7 which are similar
in overall compaction but have signiﬁcant differences in secondary
structural content and persistent tertiary structural interactions.
We show how information about side-chain accessibility in the dif-
ferent conformational states (native, partially folded and globally
unfolded) obtained by use of FPOP coupled with MS analyses is
complementary to the results from HDX which report on the struc-
ture and solvent accessibility of the main-chain, and also to direct
measurements of dynamics made by using NMR spectroscopy.
Moreover, the rapid timescale of FPOP avoids conformational aver-
aging, which often precludes direct structural analyses of non-na-
tive states using NMR. FPOP thus adds to the arsenal of techniques
now available to interrogate protein folding and dynamics, promis-
ing new information about the role of individual side-chains in
determining the nature of protein folding energy landscapes.
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